The Claim
Pharmacological inhibition of PEPCK1 using hydrazinium sulfate increases survival in Drosophila melanogaster with Ras/Src-induced tumors under high-sugar dietary conditions, and this effect is enhanced by genetic knockdown of pepck1.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In fruit flies with cancer caused by Ras/Src mutations and fed a high-sugar diet, blocking the PEPCK1 enzyme with hydrazinium sulfate extends lifespan, and this effect is stronger when the pepck1 gene is also turned off.
See the scientific wording
Pharmacological inhibition of PEPCK1 with hydrazinium sulfate improves survival in Drosophila with Ras/Src tumors under high-sugar conditions, particularly when combined with genetic knockdown of pepck1, suggesting PEPCK1 is a viable therapeutic target in this model.
When sugar intake is high, tumor cells turn on a gene called PEPCK1, which rewires their metabolism to produce more energy-building blocks and signaling molecules. This causes the tumor cells to multiply faster, avoid dying, and take up more sugar. Blocking PEPCK1 stops this process, starving the tumor and triggering cell death, which lets the organism live longer.
What the research says
1 studyStudy: High sugar diet promotes tumor progression paradoxically through aberrant upregulation of pepck1
In fruit flies with cancer and a sugary diet, blocking the PEPCK1 enzyme made them live longer, especially when scientists also turned down the gene that makes this enzyme. This suggests that drugs targeting PEPCK1 could help treat certain cancers.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.